The Nutrition for Growth Year of Action got off to an auspicious start at a virtual launch event last month, where prominent stakeholders announced investment commitments of more than $3 billion toward the upcoming Nutrition for Growth Summit‘s goal of addressing the hunger and nutrition crisis.
Developing safe and effective vaccines is only the beginning of the story. Now, the world has to get those doses out to everyone who needs them — in high-income and low-income countries alike
Preliminary results of a Phase 3, randomized, placebo-controlled clinical trial testing the investigative monoclonal antibody LY-CoV555 in hospitalized COVID-19 patients were published today in The New England Journal of Medicine.
National Institutes of Health researchers have isolated a set of promising, tiny antibodies, or “nanobodies,” against SARS-CoV-2 that were produced by a llama named Cormac.
Several high-profile papers on COVID-19 research have come under fire from people in the scientific community in recent weeks. Two articles addressing the safety of certain drugs when taken by COVID-19 patients were retracted, and researchers are calling for the retraction of a third paper that evaluated behaviors that mitigate coronavirus transmission.
The World Health Organization held a two half-day virtual summit on 1 and 2 July, to take stock of the evolving science on COVID-19 and examine progress made so far in developing effective health tools to improve the global response to the pandemic.
Heads of state and global health leaders today made an unprecedented commitment to work together to accelerate the development and production of new vaccines, tests and treatments for COVID-19 and assure equitable access worldwide.
Specimen-news.com 